dr peter attia semaglutide Do GLP-1 receptor agonists improve cardiovascular health independently of weight loss? Cardiovascular benefits of GLP-1 drugs

PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights directly relevant to GLP-1 medication response

Image credit: niksdope/Shutterstock.com In a preliminary human study published in Scientific Reports , researchers investigated whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide (Ozempic), could alter the body's physiological and psychological response to alcohol

Im saving your ass

The reset hypothesis: lactation and maternal metabolism

As a result, semaglutide continues to be recognized as the leading GLP-1 option for patients seeking evidence-based, medically supervised weight management in 2026